3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives
US8258122B2 · kind B2 · utility
2Cited by
5References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 29, 2008 |
| Grant date | Sep 4, 2012 |
| Priority date | — |
| Expiry date | Sep 11, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
New inhibitors of the p38 mitogen-activated protein kinase having the general formula (I) are disclosed herein, as well as processes for their preparation, pharmaceutical compositions comprising them, and their use in therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.